Esta é uma versão desatualizada publicada em 2024-01-09. Leia a versão mais recente.
Tratamiento farmacológico del hipertiroidismo actualmente.
Agências de fomento
Universidad Autónoma del Estado de México
Resumo
El hipertiroidismo puede desenlazar en enfermedad cardiovascular fatal, así como repercutir sobre el sistema musculo-esqueletico, con el subsecuente desarrollo de osteoporosis.
En este sentido es necesario actualizar el conocimiento farmacológico del personal de salud para el correcto tratamiento de la enfermedad tiroidea. Se recomienda iniciar con antitiroideos y observar la respeuesta terapeutica al 18 meses con monitores bi o trimestrales, así como agregar como complemento otros farmacos como β-bloqueadores, colestiramina, perclorato
Palavras-chave
hipertiroidismo, tratamiento, Enfermedad de Graves
Referências
- Abbara A, Clarke SA, Brewster R et al. (2020). Pharmacodynamic Response to Anti-thyroid Drugs in Graves’ Hyperthyroidism. Frontiers in Endocrinology; 11.
- Bartalena, L., Bogazzi, F., Chiovato, L., Hubalewska-Dydejczyk, A., Links, T. P., & Vanderpump, M. (2018). 2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction. European thyroid journal, 7(2), 55–66. https://doi.org/10.1159/000486957
- Burch HB., & Cooper DS. (2015). Management of Graves Disease: A Review. JAMA, 314(23), 2544–2554. https://doi.org/10.1001/jama.2015.16535
- Calissendorff, J., & Falhammar, H. (2017). Lugol's solution and other iodide preparations: perspectives and research directions in Graves' disease. Endocrine, 58(3), 467–473. https://doi.org/10.1007/s12020-017-1461-8
- Duntas LH, Tseleni-Balafouta, S. (2018). Classification of Thyroid Diseases. En: Luster M, DuntasLH. Warftosky L. The Thyroid and Its Diseases. 87-99. Springer. https://doi.org/10.4183/aeb.2018.574
- Ehrenkranz J., Bach PR., Snow GL., Schneider A., Lee JL., Ilstrup S., Bennett ST. & Benvenga S. (2015). Circadian and Circannual Rhythms in Thyroid Hormones: Determining the TSH and Free T4 Reference Intervals Based Upon Time of Day, Age, and Sex. Thyroid : official journal of the American Thyroid Association, 25(8), 954–961. https://doi.org/10.1089/thy.2014.0589
- Hoermann R., Midgley JE., Larisch, R., Dietrich JW. (2015). Homeostatic Control of the Thyroid-Pituitary Axis: Perspectives for Diagnosis and Treatment. Frontiers in endocrinology, 6, 177. https://doi.org/10.3389/fendo.2015.00177
- Hoermann R., Midgley JE., Larisch R., Dietrich JW. (2016). Relational Stability in the Expression of Normality, Variation, and Control of Thyroid Function. Frontiers in endocrinology, 7, 142. https://doi.org/10.3389/fendo.2016.00142
- Kahaly, G. J., Bartalena, L., Hegedüs, L., Leenhardt, L., Poppe, K., & Pearce, S. H. (2018). 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism. European thyroid journal, 7(4), 167–186. https://doi.org/10.1159/000490384
- Knight, C. L., Cooray, S. D., Kulkarni, J., Borschmann, M., & Kotowicz, M. (2017). Thyroidectomy for the treatment of Graves' thyrotoxicosis in thioamide-induced agranulocytosis and sepsis. Endocrinology, diabetes & metabolism case reports, 2017, 17-0071. https://doi.org/10.1530/EDM-17-0071
- Kravets I. (2016). Hyperthyroidism: Diagnosis and Treatment. American family physician, 93(5), 363–370.
- Lane, LC, Cheetham T. (2020) Graves’ disease: developments in first-line antithyroid drugs in the young. Expert Review of Endocrinology & Metabolism; 15(2), 59-69.
- Taylor, P. N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J. H., Dayan, C. M., & Okosieme, O. E. (2018). Global epidemiology of hyperthyroidism and hypothyroidism. Nature reviews. Endocrinology, 14(5), 301–316. https://doi.org/10.1038/nrendo.2018.18
- Prakash, I., Nylen, E. S., & Sen, S. (2015). Lithium as an Alternative Option in Graves Thyrotoxicosis. Case reports in endocrinology, 2015, 869343.https://doi.org/10.1155/2015/869343
- Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., & Walter, M. A. (2016). 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid : official journal of the American Thyroid Association, 26(10), 1343–1421. https://doi.org/10.1089/thy.2016.0229
- Sheehan MT. (2016). Biochemical Testing of the Thyroid: TSH is the Best and, Oftentimes, Only Test Needed - A Review for Primary Care. Clinical medicine & research, 14(2), 83–92. https://doi.org/10.3121/cmr.2016.1309
- Suwansaksri, N., Preechasuk, L., & Kunavisarut, T. (2018). Nonthionamide Drugs for the Treatment of Hyperthyroidism: From Present to Future. International journal of endocrinology, 2018, 5794054. https://doi.org/10.1155/2018/5794054
- Wang M, Yu Y. (2020) Therapeutic effects of combination regimens including methimazole on graves'hyperthyroidism:a network meta-analysis of randomized controlled trials. Endocrine Pra
- Werner SC. (1969). Classification of Thyroid Disease. https://doi.org/10.1210/jcem-29-6-860
- Wondisford FE. (2020) Thyroid Pharmacology. In Essentials of Endocrinology and
- Metabolism. Springer,Cham. 89-92.
- Winther, K. H., Bonnema, S. J., & Hegedüs, L. (2017). Is selenium supplementation in autoimmune thyroid diseases justified?. Current opinion in endocrinology, diabetes, and obesity, 24(5), 348–355. https://doi.org/10.1097/MED.0000000000000356
- Yang, J., Zhu, Y. J., Zhong, J. J., Zhang, J., Weng, W. W., Liu, Z. F., Xu, Q., & Dong, M. J. (2016). Characteristics of Antithyroid Drug-Induced Agranulocytosis in Patients with Hyperthyroidism: A Retrospective Analysis of 114 Cases in a Single Institution in China Involving 9690 Patients Referred for Radioiodine Treatment Over 15 Years. Thyroid : official journal of the American Thyroid Association, 26(5), 627–633. https://doi.org/10.1089/thy.2015.0439
Downloads
Não há dados estatísticos.